{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:08:19Z","timestamp":1767035299411,"version":"3.46.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00702-025-02906-2","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T12:59:36Z","timestamp":1742043576000},"page":"1765-1777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antinociceptive properties of intravesical\/needle-free administration of abobotulinumtoxinA in a rodent model of chronic visceral pain: in vivo and histological evidence"],"prefix":"10.1007","volume":"132","author":[{"given":"C\u00e9line","family":"Aug\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Lezmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lluel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-5593","authenticated-orcid":false,"given":"Jacquie","family":"Maignel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"2906_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis A, Popat R, Yiangou Y, Cockayne D, Ford AP, Davis JB, Dasgupta P, Fowler CJ, Anand P (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174:977\u2013982 (discussion 982\u2013973)","journal-title":"J Urol"},{"issue":"2","key":"2906_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/sj.bjp.0706975","volume":"150","author":"S Asfaha","year":"2007","unstructured":"Asfaha S, Cenac N, Houle S, Altier C, Papez MD, Nguyen C, Steinhoff M, Chapman K, Zamponi GW, Vergnolle N (2007) Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br J Pharmacol 150(2):176\u2013185. https:\/\/doi.org\/10.1038\/sj.bjp.0706975. (Epub 2006. PMID: 17179954; PMCID: PMC2042908)","journal-title":"Br J Pharmacol"},{"key":"2906_CR3","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.123.002081","author":"S Ashraf","year":"2024","unstructured":"Ashraf S, Clarkson T, Malykhina AP (2024) Therapeutic approaches for UCPPS management. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/jpet.123.002081","journal-title":"J Pharmacol Exp Ther"},{"key":"2906_CR43","doi-asserted-by":"publisher","unstructured":"Aug\u00e9 C, Chene G, Dubourdeau M, Desoubzdanne D, Corman B, Palea S, Lluel P, Vergnolle N, Coelho AM (2013) Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder. Eur J Pharmacol 707(1\u20133):32\u201340. https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.008","DOI":"10.1016\/j.ejphar.2013.03.008"},{"key":"2906_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3389\/fphar.2020.01305","volume":"11","author":"C Aug\u00e9","year":"2020","unstructured":"Aug\u00e9 C, Gam\u00e9 X, Vergnolle N, Lluel P, Chabot S (2020) Characterization and validation of a chronic model of cyclophosphamide-induced interstitial cystitis\/bladder pain syndrome in rats. Front Pharmacol 11:1305. https:\/\/doi.org\/10.3389\/fphar.2020.01305. (PMID: 32982733; PMCID: PMC7485435)","journal-title":"Front Pharmacol"},{"key":"2906_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2021.64270","volume":"2","author":"C Aug\u00e9","year":"2021","unstructured":"Aug\u00e9 C, Basso L, Blanpied C, Vergnolle N, Gam\u00e9 X, Chabot S, Lluel P, Dietrich G (2021) Pain management in a model of interstitial cystitis\/bladder pain syndrome by a vaccinal strategy. Front Pain Res (Lausanne) 2:642706. https:\/\/doi.org\/10.3389\/fpain.2021.64270","journal-title":"Front Pain Res (Lausanne)"},{"issue":"2","key":"2906_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","volume":"186","author":"SH Berry","year":"2011","unstructured":"Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, Nyberg L, Clemens JQ (2011) Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States. J Urol 186(2):540\u2013544. https:\/\/doi.org\/10.1016\/j.juro.2011.03.132","journal-title":"J Urol"},{"issue":"7","key":"2906_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/toxins8070201","volume":"8","author":"B Chiu","year":"2016","unstructured":"Chiu B, Tai HC, Chung SD, Birder LA (2016) Botulinum toxin A for bladder pain syndrome\/interstitial cystitis. Toxins (Basel) 8(7):201. https:\/\/doi.org\/10.3390\/toxins8070201","journal-title":"Toxins (Basel)"},{"issue":"4 Pt 1","key":"2906_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","volume":"172","author":"YC Chuang","year":"2004","unstructured":"Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB (2004) Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 172(4 Pt 1):1529\u20131532. https:\/\/doi.org\/10.1097\/01.ju.0000137844.77524.97. (PMID: 15371885)","journal-title":"J Urol"},{"issue":"2","key":"2906_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.juro.2009.03.083","volume":"182","author":"YC Chuang","year":"2009","unstructured":"Chuang YC, Tyagi P, Huang CC, Yoshimura N, Wu M, Kaufman J, Chancellor MB (2009) Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes. J Urol 182(2):786\u2013792. https:\/\/doi.org\/10.1016\/j.juro.2009.03.083. (Epub 2009 Jun 18 PMID: 19539320)","journal-title":"J Urol"},{"issue":"2","key":"2906_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.juro.2015.12.078","volume":"196","author":"YC Chuang","year":"2016","unstructured":"Chuang YC, Huang TL, Tyagi P, Huang CC (2016) Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin a delivery using low energy shock waves. J Urol 196(2):599\u2013608. https:\/\/doi.org\/10.1016\/j.juro.2015.12.078. (Epub 2015 Dec 24 PMID: 26724396)","journal-title":"J Urol"},{"issue":"5","key":"2906_CR11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E Comp\u00e9rat","year":"2006","unstructured":"Comp\u00e9rat E, Reitz A, Delcourt A, Capron F, Denys P, Chartier-Kastler E (2006) Histologic features in the urinary bladder wall affected from neurogenic overactivity\u2014a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 50(5):1058\u20131064. https:\/\/doi.org\/10.1016\/j.eururo.2006.01.025. (Epub 2006 Feb 6 PMID: 16517054)","journal-title":"Eur Urol"},{"key":"2906_CR12","volume-title":"Female genitourinary and pelvic floor reconstruction","author":"F Cruz","year":"2023","unstructured":"Cruz F, Pinto R, Mendes PA (2023) Bladder pain syndrome: interstitial cystitis. In: Martins FE, Holm HV, Sandhu J, McCammon KA (eds) Female genitourinary and pelvic floor reconstruction. Springer, Cham"},{"key":"2906_CR45","doi-asserted-by":"crossref","unstructured":"Digesu GA, Tailor V, Bhide AA, Khullar V (2020) The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS? Int Urogynecol J 31(7):1387\u20131392","DOI":"10.1007\/s00192-020-04303-7"},{"key":"2906_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-642-33570-9_11","volume":"364","author":"MB Dorner","year":"2013","unstructured":"Dorner MB, Schulz KM, Kull S, Dorner BG (2013) Complexity of botulinum neurotoxins: challenges for detection technology. Curr Top Microbiol Immunol 364:219\u2013255. https:\/\/doi.org\/10.1007\/978-3-642-33570-9_11","journal-title":"Curr Top Microbiol Immunol"},{"key":"2906_CR44","doi-asserted-by":"crossref","unstructured":"Field M, Splevins A, Picaut P, van der Schans M, Langenberg J, Noort D, Snyder D, Foster K (2018) AbobotulinumtoxinA (Dysport\u00ae), OnabotulinumtoxinA (Botox\u00ae), and IncobotulinumtoxinA (Xeomin\u00ae) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins (Basel) 10(12):535","DOI":"10.3390\/toxins10120535"},{"key":"2906_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2147\/BTT.S14902","volume":"4","author":"J Frevert","year":"2010","unstructured":"Frevert J, Dressler D (2010) Complexing proteins in botulinum toxin type A drugs: a help or a hindrance? Biologics 4:325\u2013332. https:\/\/doi.org\/10.2147\/BTT.S14902","journal-title":"Biologics"},{"issue":"1","key":"2906_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00441-018-2965-0","volume":"376","author":"G Gabella","year":"2019","unstructured":"Gabella G (2019) Afferent nerve fibres in the wall of the rat urinary bladder. Cell Tissue Res 376(1):25\u201335. https:\/\/doi.org\/10.1007\/s00441-018-2965-0","journal-title":"Cell Tissue Res"},{"key":"2906_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00192-012-1832-x","volume":"24","author":"A Gafni-Kane","year":"2013","unstructured":"Gafni-Kane A, Botros SM, Du H et al (2013) Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome\/interstitial cystitis. Int Urogynecol J 24:303","journal-title":"Int Urogynecol J"},{"key":"2906_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/iju.14234","volume":"27","author":"Y Homma","year":"2020","unstructured":"Homma Y, Akiyama Y, Tomoe H, Furuta A, Ueda T, Maeda D, Lin AT, Kuo H-C, Lee M-H, Oh S-J et al (2020) Clinical guidelines for interstitial cystitis\/bladder pain syndrome. Int J Urol 27:578\u2013589. https:\/\/doi.org\/10.1111\/iju.14234","journal-title":"Int J Urol"},{"issue":"15","key":"2906_CR18","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.3390\/ijms25158015","volume":"25","author":"JC Hu","year":"2024","unstructured":"Hu JC, Tzeng HT, Lee WC, Li JR, Chuang YC (2024) Promising experimental treatment in animal models and human studies of interstitial cystitis\/bladder pain syndrome. Int J Mol Sci 25(15):8015. https:\/\/doi.org\/10.3390\/ijms25158015. (PMID: 39125584; PMCID: PMC11312208)","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2906_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/toxins16010030","volume":"16","author":"H Ibrahim","year":"2024","unstructured":"Ibrahim H, Retailleau K, Hornby F, Maignel J, Beard M, Daly DM (2024) A novel catalytically inactive construct of botulinum neurotoxin A (BoNT\/A) directly inhibits visceral sensory signalling. Toxins (Basel) 16(1):30. https:\/\/doi.org\/10.3390\/toxins16010030","journal-title":"Toxins (Basel)"},{"issue":"6","key":"2906_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198816","volume":"13","author":"J-F Jhang","year":"2018","unstructured":"Jhang J-F, Ho H-C, Jiang Y-H, Lee C-L, Hsu Y-H, Kuo H-C (2018) Electron microscopic characteristics of interstitial cystitis\/bladder pain syndrome and their association with clinical condition. PLoS ONE 13(6):e0198816. https:\/\/doi.org\/10.1371\/journal.pone.0198816","journal-title":"PLoS ONE"},{"issue":"2","key":"2906_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/biomedicines10020396","volume":"10","author":"YH Jiang","year":"2022","unstructured":"Jiang YH, Jhang JF, Lee YK, Kuo HC (2022) Low-energy shock wave plus intravesical instillation of botulinum toxin A for interstitial cystitis\/bladder pain syndrome: pathophysiology and preliminary result of a novel minimally invasive treatment. Biomedicines 10(2):396. https:\/\/doi.org\/10.3390\/biomedicines10020396. (PMID: 35203604; PMCID: PMC8962423)","journal-title":"Biomedicines"},{"key":"2906_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/2338","volume":"5","author":"D Lacy","year":"1998","unstructured":"Lacy D, Tepp W, Cohen A et al (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Mol Biol 5:898\u2013902. https:\/\/doi.org\/10.1038\/2338","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"2906_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3978\/j.issn.2223-4683.2015.10.02","volume":"4","author":"NS Lamarre","year":"2015","unstructured":"Lamarre NS, Bjorling DE (2015) Treatment of painful bladder syndrome\/interstitial cystitis with botulinum toxin A: why isn\u2019t it effective in all patients? Transl Androl Urol 4(5):543\u2013554. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2015.10.02","journal-title":"Transl Androl Urol"},{"issue":"5","key":"2906_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/toxins16050225","volume":"16","author":"V Martin","year":"2024","unstructured":"Martin V, Carre D, Bilbault H, Oster S, Limana L, Sebal F, Favre-Guilmard C, Kalinichev M, Leveque C, Boulifard V, George C, Lezmi S (2024) Intramuscular botulinum neurotoxin serotypes E and A elicit distinct effects on SNAP25 protein fragments, muscular histology, spread and neuronal transport: an integrated histology-based study in the rat. Toxins (Basel) 16(5):225. https:\/\/doi.org\/10.3390\/toxins16050225","journal-title":"Toxins (Basel)"},{"key":"2906_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","volume":"119\u2013120","author":"I Matak","year":"2014","unstructured":"Matak I, Lackovi\u0107 Z (2014) Botulinum toxin A, brain and pain. Prog Neurobiol 119\u2013120:39\u201359. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.06.001","journal-title":"Prog Neurobiol"},{"key":"2906_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tox.2015.07.003","volume":"335","author":"I Matak","year":"2015","unstructured":"Matak I, Lackovi\u0107 Z (2015) Botulinum neurotoxin type A: actions beyond SNAP-25? Toxicology 335:79\u201384. https:\/\/doi.org\/10.1016\/j.tox.2015.07.003","journal-title":"Toxicology"},{"issue":"8","key":"2906_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/toxins11080459","volume":"11","author":"I Matak","year":"2019","unstructured":"Matak I, B\u00f6lcskei K, Bach-Rojecky L, Helyes Z (2019) Mechanisms of botulinum toxin type A action on pain. Toxins (Basel) 11(8):459. https:\/\/doi.org\/10.3390\/toxins11080459. (PMID: 31387301)","journal-title":"Toxins (Basel)"},{"issue":"4","key":"2906_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/bju.13163","volume":"117","author":"D Papagiannopoulou","year":"2016","unstructured":"Papagiannopoulou D, Vardouli L, Dimitriadis F, Apostolidis A (2016) Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats. BJU Int 117(4):697\u2013704. https:\/\/doi.org\/10.1111\/bju.13163","journal-title":"BJU Int"},{"issue":"5","key":"2906_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.857","volume":"9","author":"C P\u00e9rier","year":"2021","unstructured":"P\u00e9rier C, Martin V, Cornet S, Favre-Guilmard C, Rocher MN, Bindler J, Wagner S, Andriambeloson E, Rudkin B, Marty R, Vignaud A, Beard M, Lezmi S, Kalinichev M (2021) Recombinant botulinum neurotoxin serotype A1 in vivo characterization. Pharmacol Res Perspect 9(5):e00857. https:\/\/doi.org\/10.1002\/prp2.857","journal-title":"Pharmacol Res Perspect"},{"key":"2906_CR46","doi-asserted-by":"crossref","unstructured":"Plotti F, Cundari GB, Ficarola F, Terranova C, De Cicco Nardone C, Montera R, Luvero D, Guzzo F, Silvagni A, Ferrari A, Caserta D, Angioli R (2024) Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis\/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life. Healthcare (Basel) 12(12):1190","DOI":"10.3390\/healthcare12121190"},{"key":"2906_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11884-023-00695-6","volume":"18","author":"MS Rahnama\u2019i","year":"2023","unstructured":"Rahnama\u2019i MS, Javan Balegh Marand A, Janssen D, Mostafaei H, Gatsos S, Hajebrahimi S, Apostolidis A, Taneja R (2023) Botulinum toxin therapy for bladder pain syndrome\/interstitial cystitis. Curr Bladder Dysfunct Rep 18:147\u2013153. https:\/\/doi.org\/10.1007\/s11884-023-00695-6","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"S4","key":"2906_CR31","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/nau.23493","volume":"37","author":"MS Rahnama'i","year":"2018","unstructured":"Rahnama\u2019i MS, Marcelissen T, Apostolidis A, Veit-Rubin N, Schurch B, Cardozo L, Dmochowski R (2018) The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)\/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank. Bristol Neurourol Urodyn 37(S4):S99\u2013S107. https:\/\/doi.org\/10.1002\/nau.23493","journal-title":"Bristol Neurourol Urodyn"},{"key":"2906_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.urology.2017.12.028","volume":"114","author":"YH Rappaport","year":"2018","unstructured":"Rappaport YH, Zisman A, Jeshurun-Gutshtat M, Gerassi T, Hakim G, Vinshtok Y, Stav K (2018) Safety and feasibility of intravesical instillation of botulinum toxin-A in hydrogel-based slow-release delivery system in patients with interstitial cystitis-bladder pain syndrome: a pilot study. Urology 114:60\u201365. https:\/\/doi.org\/10.1016\/j.urology.2017.12.028. (ISSN 0090-4295)","journal-title":"Urology"},{"issue":"10","key":"2906_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111238","volume":"9","author":"JM Scherf","year":"2014","unstructured":"Scherf JM, Hu XS, Tepp WH, Ichtchenko K, Johnson EA, Pellett S (2014) Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative. PLoS ONE 9(10):e111238. https:\/\/doi.org\/10.1371\/journal.pone.0111238","journal-title":"PLoS ONE"},{"key":"2906_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1056\/NEJM200003023420918","volume":"342","author":"B Schurch","year":"2000","unstructured":"Schurch B, Schmid DM, Stohrer M (2000) Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342:665","journal-title":"N Engl J Med"},{"issue":"12","key":"2906_CR35","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/biology10121316","volume":"10","author":"J-D Shen","year":"2021","unstructured":"Shen J-D, Chen S-J, Chen H-Y, Chiu K-Y, Chen Y-H, Chen W-C (2021) Review of animal models to study urinary bladder function. Biology 10(12):1316. https:\/\/doi.org\/10.3390\/biology10121316","journal-title":"Biology"},{"key":"2906_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.urology.2012.03.030","volume":"80","author":"K Stav","year":"2012","unstructured":"Stav K, Beberashvili I, Lindner A et al (2012) Predictors of response to intravesical dimethyl-sulfoxide cocktail in patients with interstitial cystitis. Urology 80:61","journal-title":"Urology"},{"key":"2906_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1232017","author":"C Tay","year":"2023","unstructured":"Tay C, Grundy L (2023) Animal models of interstitial cystitis\/bladder pain syndrome. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2023.1232017","journal-title":"Front Physiol"},{"issue":"5","key":"2906_CR38","first-page":"346","volume":"7","author":"F Torkamand","year":"2019","unstructured":"Torkamand F, Mirjavadi SJ, Khatami F, Guitynavard F, Aghamir SMK (2019) Evaluation of several botulinum toxins\u2014a delivering systems into the bladder in interstitial cystitis\/painful bladder syndrome (IC\/PBS). Am J Clin Exp Urol 7(5):346\u2013351","journal-title":"Am J Clin Exp Urol"},{"issue":"2","key":"2906_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/MOU.0000000000001158","volume":"34","author":"J Tornic","year":"2024","unstructured":"Tornic J, Engeler D (2024) Latest insights into the pathophysiology of bladder pain syndrome\/interstitial cystitis. Curr Opin Urol 34(2):84\u201388. https:\/\/doi.org\/10.1097\/MOU.0000000000001158","journal-title":"Curr Opin Urol"},{"issue":"2","key":"2906_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","volume":"173","author":"VM Vemulakonda","year":"2005","unstructured":"Vemulakonda VM, Somogyi GT, Kiss S, Salas NA, Boone TB, Smith CP (2005) Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation. J Urol 173(2):621\u2013624","journal-title":"J Urol"},{"issue":"6","key":"2906_CR41","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/nau.23141","volume":"36","author":"HJ Wang","year":"2017","unstructured":"Wang HJ, Lee WC, Tyagi P, Huang CC, Chuang YC (2017) Effects of low energy shock wave therapy on inflammatory moleculars, bladder pain, and bladder function in a rat cystitis model. Neurourol Urodyn 36(6):1440\u20131447. https:\/\/doi.org\/10.1002\/nau.23141. (Epub 2016 Dec 30)","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 1","key":"2906_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/iju.13971","volume":"26","author":"KE Whitmore","year":"2019","unstructured":"Whitmore KE, Fall M, Sengiku A, Tomoe H, Logadottir Y, Kim YH (2019) Hunner lesion versus non-Hunner lesion interstitial cystitis\/bladder pain syndrome. Int J Urol 26(Suppl 1):26\u201334. https:\/\/doi.org\/10.1111\/iju.13971","journal-title":"Int J Urol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02906-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:47:28Z","timestamp":1764600448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02906-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2906"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02906-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"type":"print","value":"0300-9564"},{"type":"electronic","value":"1435-1463"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jacquie Maignel, Vincent Martin, Mathieu Vogt and St\u00e9phane Lezmi (current employee of Excilone Services, Inrae site, Bat 221, Domaine de Vilvert, 4 avenue Jean Jaur\u00e8s, 78352 Jouy-en-Josas, France) are or were IPSEN employees when this study was set up, run and analyzed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}